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Abstract In ~-escin-permeabilized cultured pig aortic smooth 
muscle cells GTP2/S dose-dependently enhances Ca2÷-induced, 
wortmannin-sensitive phosphorylation of 20 kDa myosin light 
chain (MLC~o). GTP~S does not potentiate thiophosphorylation 
of MLCzo, but does inhibit its dephosphorylation. Pretreatment 
with C. botulinum exotoxin C3, which specifically ADP-ribosyl- 
ates and inactivates the rho family of the small molecular weight 
G proteins, completely abolishes the effects of GTPyS. These 
results indicate that rho is involved in the GTP?/S-induced en- 
hancement of Ca2+-dependent MLC20 phosphorylation in aortic 
smooth muscle cells, and strongly suggest that this effect of 
rho is due to inhibition of protein phosphatase activity toward 
MLC2o. 
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1. Introduction 
Vasoconstrictor stimulation of smooth muscle induces a rise 
in the intracellular free Ca 2+ concentration ([Ca2+]3 and activa- 
tion of the Ca 2+, calmodulin-dependent zyme, myosin light 
chain kinase (MLCK) [1,2]. It is now generally accepted that 
the resultant phosphorylation of the 20 kDa myosin light chain 
(MLC20) leads to the interaction of actin with myosin, trigger- 
ing a contractile response [2]. Recent studies have shown that 
the [Ca2+]~ isnot the sole determinant for the extent of phospho- 
rylation of MLC20 achieved by agonist stimulation [3-7]. Thus, 
as compared to KC1 depolarization, excitatory agonist consist- 
ently produces larger increases in both MLC20 phosphorylation 
and tension at a given level of the [Ca2+]~, implying that agonists 
somehow enhance the Ca 2+ sensitivity of both MLC20 phospho- 
rylation and contraction [3,4,6]. Indeed, it has recently been 
demonstrated in skinned smooth muscle fibers that, at a fixed 
level of [Ca2+]i, an agonist causes increases in the phospho- 
rylation level of MLC20 and tension in a GTP-dependent man- 
ner, providing evidence for the involvement of a GTP binding 
protein (G protein) in receptor-mediated sensitization of Ca 2+- 
dependent MLC20 phosphorylation [5,7,8]. To investigate in 
depth the molecular mechanism of G protein-induced potentia- 
tion of MLC20 phosphorylation, we have developed a useful 
cultured cell system of vascular smooth muscle, in which 
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GTPyS potentiates Ca2+-dependent phosphorylation of 
MLC20. By using the bacterial exoenzyme C3 which ADP-ri- 
bosylates and inactivates rho proteins [9,10], we have found that 
the small molecular weight G protein rho mediates GTPTS 
enhancement of Ca2+-dependent MLC20 phosphorylation, and 
that rho acts to inhibit MLC20 phosphatase activity. 
2. Materials and methods 
2.1. Cell culture, permeabilization a d determination fCa2+-dependent 
MLC:o phosphorylation 
Pig aortic smooth muscle cells were obtained by the explant method 
[11] and were used between the 5th and the 15th passages. Before each 
experiment, confluent cells were deprived of serum for 24 h. Cells were 
washed with Ca 2+, Mg2+-free Dulbecco's phosphate-buffered saline 
(PBS) and permeabilized with 20 pM offl-escin in buffer A comprising 
130 mM potassium glutamate, 4 mM MgC12, 2 mM EGTA, 2 mM ATP 
and 20 mM HEPES (pH 7.2) at 28°C for 10 min. After washing with 
buffer A without fl-escin, phosphorylation of cellular myosin was 
started by adding buffer A containing 0.3 ,uM bovine calmodulin and 
various concentrations of CaCI 2 to give a desired concentration f free 
Ca 2+, with or without guanosine 5'(3-O-thio)triphosphate (GTPyS) or 
other nucleotides (phosphorylation buffer). Where indicated, permea- 
bilized cells were pretreated with or without C3 in the presence of NAD 
as described below and then phosphorylation of cellular myosin was 
started. Free Ca 2+ concentrations were calculated as described previ- 
ously [12]. Under this experimental condition phosphorylation levels of 
MLC20 were found to be maintained for at least 60 min. The inclusion 
of 1 pM ionomycin in both the permeabilization a d the phosphoryla- 
tion buffers did not alter the results. The extent of MLC20 phosphoryl- 
ation was determined by glycerol-urea gel electrophoresis followed by 
quantitation of the relative amounts of non-phosphorylated and 
phosphorylated forms of MLC20 with Western blot technique [13]. 
Densities of bands corresponding to non-phosphorylated, mono- 
phosphorylated and diphosphorylated forms of MLC20 were quanti- 
tated by using a scanning densitometer (The Discovery Series, PDI). 
Percent values of monophosphorylated form, diphosphorylated form 
and the sum of both forms of total MLC20 were calculated. 
2.2. ADP-ribosylation of endogenous rho protein 
Permeabilized cells were preincubated in buffer A containing 10 ¢tM 
NAD with or without 1 pg/ml C3 at 28°C for 20 min. After a wash with 
buffer A, cells were then incubated in buffer A containing 10 pM 
32p-NAD (Dupont-NEN) in the presence or absence of 1 ktg/ml C 3 at 
28°C for 20 min. Cellular proteins were separated on SDS-poly- 
acrylamide gel electrophoresis (15%), followed by autoradiography. C 3
exoenzyme was purified from culture supernatant of Clostridium botu- 
linum type D South African (DSA) as described previously [14]. 
2.3. Dephosphorylation experiment of phosphorylated MLC2o 
Permeabilized cells were pretreated with 1 ,ug/ml C3 or left untreated 
for 25 min and then exposed to the phosphorylation buffer containing 
0.1 ,uM free Ca 2+ with or without 30/~M GTPyS for 15 min. After 
washing once with the Ca2+-free phosphorylation buffer containing 
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2 mM EGTA, cells were incubated indephosphorylation buffer of the 
same composition containing 50 pM wortmannin for indicated time 
periods and the phosphorylation level of MLC20 was determined as 
described above. Values were expressed as percent of the initial MLC20 
phosphorylation level at time zero. 
2.4. Materials 
GTPigS, guanosine 5'O-(fl-thio)diphosphate (GDPflS) and other nu- 
cleotides were purchased from Boehringer-Mannheim. fl-Escin, bovine 
calmodulin, NAD and anti-MLC20 antibody were purchased from 
Sigma. Biotinylated secondary antibody and streptoavidin-conjugated 
alkaline phosphatase were bought from Zymed. Anti-rhoA antibody 
was purchased from Santa Cruz. 
3. Results 
In fl-escin-permeabilized pig aortic smooth muscle cells, rais- 
ing the ambient free Ca 2+ concentration causes a dose-depend- 
ent increase in the extent of MLC20 phosphorylation (Fig. 1). 
The addition of the MLCK inhibitor wortmannin [15] com- 
pletely inhibits Ca2+-induced MLC20 phosphorylation, suggest- 
ing that CaZ+-induced phosphorylation f MLC20 is mediated 
by MLCK. The addition of GTP?'S (30 tiM) potently enhances 
Ca2+-induced MLC20 phosphorylation: GTP),S causes an in- 
crease in the level of monophosphorylated MLC20 and appear- 
ance of diphosphorylated MLC20 (see Figs. 1 and 2A). GTP?,S 
shifts the Ca2+-MLC20 phosphorylation curve to the left by 
approximately one order of magnitude and also slightly in- 
creases the maximal level of MLC20 phosphorylation. The addi- 
tion of 100 tM of GTP also causes an increase in MLC20 
phosphorylation at 0.1 t M Ca 2+, although to a lesser extent as 
compared to 30 tM of GTP),S. Thus, the non-hydrolyzable 
GTP analogue GTP?'S appears to be more potent han GTP. 
In contrast, both CTP and UTP at 100 tM are totally ineffec- 
tive. Either GDP or GDPflS has no effect on Ca2+-induced 
MLC20 phosphorylation. When GDPflS (1 mM) is added be- 
fore GTP or GTP),S, it completely inhibits the enhancing ef- 
fects of these guanine nucleotides. 
Western blot analysis using anti-rhoA antibody demonstrates 
that aortic smooth muscle cells contain abundant rho proteins 
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Fig. 1. Ca2+-MLC20 phosphorylation relationship n the presence and 
absence of GTPyS in fl-escin-permeabilized pigaortic smooth muscle 
cells. Permeabilized cells were incubated in various concentrations of
free Ca z+ with or without 30,uM GTP),S for 15 min. The level of MLC20 
phosphorylation was determined as described in section 2. Each value 
represents he mean + S.E.M. of four determinations. 
and that the permeabilization procedure does not cause any 
detectable oss of rho proteins out of cells. In order to examine 
the role of rho in GTPyS-induced enhancement of MLC20 phos- 
phorylation, we investigated the effect of the botulinum exoen- 
zyme C3 [9,10]. As shown in Fig. 2A and B, pretreatment of
permeabilized cells with C3 (1.0 ¢tg/ml) for 20 min completely 
inhibits GTPyS enhancement of Ca2+-induced MLC20 phos- 
phorylation. In the absence of GTPyS, C3 is without effect on 
Ca2+-induced phosphorylation f MLC20. The effectiveness of
the C3 activity in permeabilized cells is proven by the fact shown 
in Fig. 2C that a protein with apparent Mr of 23 kDa in perme- 
abilized cells is fully ADP-ribosylated by the incubation with 
C 3 and [32p]NAD. Thus, when cells are first pretreated with C3 
and non-radiolabeled NAD for 20 min, the following second 
incubation with C3 and [32p]NAD does not cause any further 
ADP-ribosylation of the 23 kDa protein, indicating that the 
first incubation with C3 causes full ADP-ribosylation of rho. It 
has been reported that ADP-ribosylation of purified 21 kDa 
rho protein causes decreased mobility on electrophoresis [16]. 
GTP~'S-induced enhancement of MLC20 phosphorylation 
could result from GTPyS-mediated potentiation of MLCK ac- 
tivity, or alternatively, inhibition of protein phosphatase activ- 
ity toward MLC20. To discriminate between the two possibili- 
ties, we conducted following experiments. First, we studied 
whether GTP)'S increases thiophosphorylation of MLC20. Thi- 
ophosphorylated MLC20 is a very poor substrate for phosphat- 
ase [17]. As shown in Fig. 3A, when ATP is included as sub- 
strate in the absence of GTP?'S, the addition of 0.1 tM Ca 2+ 
causes a rapid increase in the phosphorylation level of MLC20 
up to about 50% of total MLCz0 by 2 min, which is maintained 
for 10 rain. In the presence of GTPyS, the extent of MLC20 
phosphorylation is further potentiated at every time point ex- 
amined. When ATPyS is used as substrate in stead of ATP (Fig. 
3B), the level of MLC20 thiophosphorylation continues to rise 
for up to 10 min and reaches higher levels than those achieved 
with ATP (compare Figs. 3A and B). Importantly, GTPyS does 
not cause any further increase in the thiophosphorylation level 
of MLC2o at any time point. These results indicate that GTP),S 
does not potentiate the activity of MLCK. 
In the second set of experiments, we examined whether 
GTP),S affects dephosphorylation f phosphorylated MLC20 
and, if so, whether C3 pretreatment i hibits the effect of GTP?,S 
on MLCz0 dephosphorylation n permeabilized cells. After cells 
were preincubated with or without C3, MLC20 was made 
phosphorylated byintroducing Ca z+ (0.1 tM)  alone or together 
with GTP),S (30 /tM). Cells were then transferred to the 
dephosphorylation buffer containing 2 mM EGTA and the 
MLCK inhibitor wortmannin, and MLC20 dephosphorylation 
started. As shown in Fig. 4, in control cells without C3 pretreat- 
ment the phosphorylation level of MLC20 rapidly falls down to 
33% of the initial level by 4 min. GTPyS potently inhibits 
dephosphorylation of MLC:0, and the phosphorylation level at 
4 min is maintained at 53% of the initial level. C3 pretreatment 
completely abolishes this effect of GTP),S and causes the 
MLC20 phosphorylation level to decrease to the level of the no 
treatment group. The MLC20 phosphorylation level is similar 
between the no treatment group and the C3 plus GTP),S group 
except at the time point of 4 min, where the difference between 
both groups is significant (P < 0.05). These results trongly sug- 
gest that GTPyS inhibits the MLC20 phosphatase activity and 
that this action of GTPyS is mediated by rho. 
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Fig. 2. Inhibition by botulinum exoenzyme C 3 of GTP~,S-induced enhancement of MLC20 phosphorylation. Permeabilized cells were pretreated with 
C3 (1 ,ug/ml) for 20 min or left untreated, and then incubated in 0.1 ,uM Ca 2÷ with or without 30/~M GTP~S for 15 min. The level of MLC20 
phosphorylation was determined as described in section 2. MLCP and MLCP2, monophosphorylated and diphosphorylated forms of MLC20. (A) 
Representative Western blot. (B) Quantitative summary of MLCP level, MLCP2 level and the sum of MLCP level plus MLCP2 level. C3 treatment 
causes complete inhibition of GTPT/S-induced enhancement of MLC20 phosphorylation. Each value represents he mean + S.E.M. of four to six 
determinations. (C) Validity of C3 treatment was confirmed in parallel dishes, in which treatment with C3 (1 ~g/ml) for 20 min had achieved the full 
extent of ADP-ribosylation of an endogenous protein of approximately 23 kDa. See text for detail. 
4. D iscuss ion  
The results in the present study demonstrate hat in permea- 
bilized pig aortic smooth muscle cells the botulinum exoenzyme 
C3, which is known to specifically ADP-ribosylate and to inac- 
tivate members of the rho family [9,10], completely abolishes 
enhancement by GTPyS of Ca2+-induced MLC20 phosphoryla- 
tion. Under the same experimental condition C3 causes com- 
plete ADP-ribosylation of an endogenous 23 kDa protein in 
permeabilized cells. These results strongly suggest hat rho is 
involved in GTPyS-induced Ca 2+ sensitization of MLC20 phos- 
phorylation in vascular smooth muscle cells. In accordance 
with previous reports for skinned vascular smooth muscle fiber 
and tracheal smooth muscle homogenates [18,19], GTP~'S 
causes inhibition of dephosphorylation of phosphorylated 
MLC20, but does not potentiate thiophosphorylation f MLC2o 
in fl-escin permeabilized cells. The present study further shows 
that this GTPTS effect on dephosphorylation f MLC2o is to- 
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Fig. 3. GTPTS does not potentiate hiophosphorylation of MLC20. Permeabilized cells were incubated in 0.1/tM Ca 2+ in the presence of 2 mM ATP 
(A) or ATPyS (B) with or without 30 pM GTP?'S for indicated time periods. The level of MLC20 phosphorylation was determined as described in 
section 2. Each value is the mean of duplicate determinations and representative of two separate experiments. 
tally abolished in C3-pretreated permeabilized cells. These re- 
sults suggest that the site of action of rho resides in regulation 
of protein phosphatase activity toward MLC20. Our results, 
together with a previous report of skinned smooth muscle that 
rho is involved in GTPTS enhancement of CaZ+-induced con- 
traction [20], strongly suggest that rho plays an important reg- 
ulatory role in agonist-induced MLC20 phosphorylation and 
contraction. 
It was recently demonstrated that the major smooth muscle 
myosin phosphatase belongs to protein phosphatase 1 (PP1) 
and is composed of three subunits, a 37 kDa catalytic subunit 
(PP1 isozyme) and 110 kDa and 20 kDa regulatory subunits 
[21]. It was also demonstrated that the regulatory components 
function to target he catalytic subunit of the smooth muscle 
protein phosphatase to myosin filament and to increase the 
phosphatase activity toward myosin. In liver and skeletal mus- 
cle, PP1 with the subunit structure similar to the smooth muscle 
myosin-associated phosphatase is found to associate with gly- 
cogen particles, where it regulates activities of enzymes in- 
volved in glycogen metabolism through dephosphorylation 
[22]. It is known for the glycogen particle-associated PP1 that 
the activity of the catalytic subunit is regulated through cova- 
lent modification of the regulatory subunit and interaction with 
allosteric effectors [22,23]. For example, adrenalin induces acti- 
vation of cyclic AMP-dependent protein kinase, which phos- 
phorylates the regulatory subunit of glycogen-associated PP1
and inhibits the phosphatase activity. Hepatic glycogen-associ- 
ated PP1 is also inhibited allosterically by the phosphorylated 
form of phosphorylase. By analogy with this, it is an intriguing 
possibility that activated rho inhibits the smooth muscle 
myosin-associated PPI through a change in phosphorylation 
state of the regulatory subunit. In this regard, it should be noted 
that rac, a small molecular weight G protein closely related to 
rho, activates a cytosolic serine/threonine protein kinase [24]. 
Alternatively, it might be possible that a complex of activated 
rho and its downstream effector induces a change in the phos- 
phatase activity by aIlosteric interaction with the regulatory 
subunit. 
In a number of smooth muscle types excitatory agonists bind 
to a rhodopsin type of membrane receptors and activate ffec- 
tor molecules uch as phospholipase C and phospholipase A 2 
via heterotrimeric G proteins. However, the mechanisms by 
which this class of agonists activate low molecular weight G 
protein(s) are not well understood. There are several known 
regulatory molecules for the rho family members including 
smgGDS, rhoGDS, rhoGDI and rhoGAP [25,26]. An agonist 
may alter activities of these regulatory molecules through acti- 
vation of a heterotrimeric G protein to bring about a change 
in the rho activity. It remains to be clarified whether and how 
an agonist exactly activates the rho family G proteins. We 
expect hat the cultured smooth muscle cell system we have 
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Fig. 4. GTPTS inhibits dephosphorylation of MLC20 in a Ca-sensitive 
manner. Permeabilized cells which had been pretreated with Ca (1 
pg/ml) or left untreated were incubated inthe dephosphorylation buffer 
for indicated time periods. The level of MLC20 phosphorylation was 
determined as described in section 2, and the values were expressed as 
percent of the initial MLC20 phosphorylation level at time zero. Each 
value represents he mean _+ S.E.M. of four determinations. The aster- 
isk (*) denotes a significant (P < 0.05) difference as compared with the 
values of the 'GTPTS' group. 
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developed would provide a useful model for further biochemi- 
cal investigation on the role of rho in the regulation of MLC20 
phosphorylation. 
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